EUR 0.1
(-3.44%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 7.25 Million EUR | 27.58% |
2022 | 5.68 Million EUR | 21.31% |
2021 | 4.68 Million EUR | -0.87% |
2020 | 4.73 Million EUR | -24.69% |
2019 | 6.28 Million EUR | -3.16% |
2018 | 6.48 Million EUR | -20.31% |
2017 | 8.13 Million EUR | -0.13% |
2016 | 8.15 Million EUR | 37.19% |
2015 | 5.94 Million EUR | -10.22% |
2014 | 6.61 Million EUR | 58.25% |
2013 | 4.18 Million EUR | 11.67% |
2012 | 3.74 Million EUR | 29.12% |
2011 | 2.89 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 6.98 Million EUR | 0.0% |
2023 Q2 | 7.96 Million EUR | 0.0% |
2023 FY | 7.25 Million EUR | 27.58% |
2023 Q4 | 7.25 Million EUR | 0.0% |
2022 Q4 | 5.68 Million EUR | 0.0% |
2022 Q2 | 7.2 Million EUR | 0.0% |
2022 FY | 5.68 Million EUR | 21.31% |
2021 Q2 | 5.27 Million EUR | 0.0% |
2021 FY | 4.68 Million EUR | -0.87% |
2021 Q4 | 4.68 Million EUR | 0.0% |
2020 Q4 | 4.72 Million EUR | 0.0% |
2020 FY | 4.73 Million EUR | -24.69% |
2020 Q2 | 5.94 Million EUR | 0.0% |
2019 Q2 | 6.68 Million EUR | 0.0% |
2019 FY | 6.28 Million EUR | -3.16% |
2019 Q4 | 6.28 Million EUR | 0.0% |
2018 Q2 | 8.14 Million EUR | 0.0% |
2018 Q4 | 6.48 Million EUR | 0.0% |
2018 FY | 6.48 Million EUR | -20.31% |
2017 Q4 | 8.13 Million EUR | 0.0% |
2017 FY | 8.13 Million EUR | -0.13% |
2017 Q2 | 7.2 Million EUR | 0.0% |
2016 Q2 | 6.03 Million EUR | 0.0% |
2016 FY | 8.15 Million EUR | 37.19% |
2016 Q4 | 8.15 Million EUR | 0.0% |
2015 Q2 | 6.09 Million EUR | 0.0% |
2015 FY | 5.94 Million EUR | -10.22% |
2015 Q4 | 5.94 Million EUR | 0.0% |
2014 FY | 6.61 Million EUR | 58.25% |
2014 Q4 | 6.61 Million EUR | 0.0% |
2014 Q2 | 4.97 Million EUR | 0.0% |
2013 FY | 4.18 Million EUR | 11.67% |
2013 Q4 | 4.18 Million EUR | 0.0% |
2013 Q2 | 2.74 Million EUR | 0.0% |
2012 FY | 3.74 Million EUR | 29.12% |
2012 Q4 | 3.74 Million EUR | 0.0% |
2011 FY | 2.89 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Crossject Société Anonyme | 33.9 Million EUR | 78.594% |
Safe Orthopaedics SA | 17.79 Million EUR | 59.223% |
Amplitude Surgical SA | 183.43 Million EUR | 96.044% |
Sartorius Stedim Biotech S.A. | 5.07 Billion EUR | 99.857% |
EssilorLuxottica Société anonyme | 21.63 Billion EUR | 99.966% |
bonyf N.V. | 411.93 Thousand EUR | -1661.681% |